Research Article
Ali Alawieh, Firas H Kobais
Abstract
Cardiovascular Diseases (CVD) remain the leading cause of death and reduced life expectancy worldwide according to the 2010 reports of the Global Burden of Disease [1,2]. CVDs affect all age groups, and the number of affected individuals is becoming more alarming, thus the importance of defining early diagnostic biomarkers, that can be helpful to detect and possibly prevent the occurrence of cardiovascular diseases and associated accidents, is of utmost importance. Ultimately these biomarkers could help establishing a personalized regimen for the treatment of a given patient and open the way for a novel drug design strategy.